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1Analysis of dose dependence curve by using Hill function approximation
Fig. S1. Approximation of pHER2 and pAKT theoretical dose dependences (red lines) by Hill function (blue lines). Curves 1  -
pAKT dose dependence. Hill coefficient n=1.9 and half-maximal concentration K=0.004. Curves 2  - pHER2 dose dependence. 
n=2.0, K=0.01. Curves 3  - pAKT dose dependence in the presence of PTEN inhibitor bpV(pic), 100 nM. n=2.2 and half-maximal 
concentration K=5·10-4.
We analysed the steepness of pHER and pAKT dose dependence curves by fitting theoretical dose dependence curve to 
the Hill equation:
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where y is output signal either pHER2 or pAKT, x – HRG concentration, n – Hill coefficient, K - half-maximal 
concentration of HRG. 
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Fig. S2. Dependence of pAKT (A) and sensitivity SSTS (B) on pHER2 input signal and control parameter γ. Arrows 
show trajectories of the pAKT (A) and sensitivity SSTS (B) changes at RTK inhibition by pertuzumab and γ changes as a 
result of PTEN activity alteration. Trajectory (1-2) shows HER2 inhibition by pertuzumab; (2-3) – γ change 
corresponding the loss of PTEN activity; (1-4) – combination of HER2 inhibition by pertuzumab and PI3K inhibition by 
LY294002; (1-2*) - 95% inhibition of HER2. The concentrations of pHER2 and pAKT are normalized to their maximal 
concentrations.
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Input-output characteristic and sensitivity of signal transduction system of 
PI3K/PTEN/AKT pathway
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Fig. S3. Effects of HER2 inhibition, PIK3CA mutation (A) and 10 times AKT overexpression (B) on sensitivity SSTS,i to the 
kinetic parameters of the enzymes involved in AKT phosphorylation. Black bars – no pertuzumab, white bars – 100 nM 
pertuzumab, grey bars - 100 nM pertuzumab and PTEN inhibition by bpV(pic). PIK3CA mutation was modeled by three times 
increase in PI3K activity.
Effects of HER2 inhibition, PIK3CA mutation, and AKT overexpression on 
sensitivity of signal transduction system, SSTS,i
4Fig. S4.  (A) Kinetics of pPTEN accumulation at HRG activation (solid line). Effect of three times increase in activity 
of CK2/GSK3β reaction of PTEN phosphorylation (dashed line) and PTEN inhibition by bpV(pic) (dotted line) on 
pPTEN kinetics. Points – experimental data [1]. (B) Effects of HER2 inhibition and three times increase in activity of 
CK2/GSK3β reaction on sensitivity SSTS,i to the kinetic parameters of the enzymes involved in AKT phosphorylation. 
Black bars – no pertuzumab, white bars – 100 nM pertuzumab, grey bars - 100 nM pertuzumab and CK2/GSK3β
overexpression. 
Post-translation modification of PTEN and sensitivity-to-resistance 
transition due to CK2/GSK3 amplification 
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5Fig. S5. Comparison of the theoretical pAKT dose dependence on pHER2 signal for PE04 ovarian carcinoma cell line 
with experimental pAKT dose dependence on phosphorylated platelet-derived growth factor receptor, pPDGFR (time-
integrated) for NIH 3T3 fibroblasts [2].
Comparison of the response-signal characteristic of signal transduction system of 
PE04 ovarian carcinoma cell line and NIH 3T3 fibroblasts 
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